secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longeveron Inc. (LGVN)
CIK:        0001721484
Form:       8-K
Filed at:   2024-04-11T23:59:59+00:00
Accession:  0001213900-24-032239
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Longeveron closes $5.2M public offering of common stock and warrants
--------------------------------------------------------------------

- Gross proceeds ~$5.2M from 2,234,043 units at $2.35/unit (share + warrant).
- Insiders (board members) participated for ~$700k.
- Existing warrants amended: exercise price reduced from $16.50 to $2.35; expiration extended.
- Net proceeds for Lomecel-B clinical trials in HLHS and Alzheimer's.
- H.C. Wainwright placement agent; 7% cash fee plus placement agent warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1721484/000121390024032239/0001213900-24-032239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1721484/000121390024032239/ea0203594-8k_longeveron.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-032239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer